Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European StudyUri Kopylov, Marc Ferrante, Daniela Pugliese et al.|Inflammatory Bowel Diseases|2018Cited by 70
DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn’s and Colitis Organisation studyUri Kopylov, Marc Ferrante, Bram Verstockt et al.|Journal of Crohn s and Colitis|2018Cited by 4